Enveric Biosciences Inc. (NASDAQ: ENVB) Stock Information | RedChip

Enveric Biosciences Inc. (NASDAQ: ENVB)


$0.3110
+0.0010 ( +2.64% ) 324.9K

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Market Data


Open


$0.3110

Previous close


$0.3100

Volume


324.9K

Market cap


$3.08M

Day range


$0.2950 - $0.3390

52 week range


$0.2955 - $2.9200

SEC Filings


Form Type Description Pages Date
8-k 8K-related 17 Dec 29, 2023
8-k 8K-related 15 Dec 28, 2023
8-k 8K-related 14 Dec 27, 2023
8-k 8K-related 14 Dec 05, 2023

Latest News